Johnson & Johnson said a combination of its lung cancer drugs Rybrevant and Lazcluze kept people alive for at least a year ...

Johnson & Johnson said its combination therapy for lung cancer outperformed AstraZeneca Plc’s blockbuster Tagrisso in a ...

Although lung cancer survival is improving in the United States, 21% of patients with lung cancer did not receive treatment ...

IMDYLLTRA offers new hope for patients with extensive-stage small cell lung cancer The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted a conditional marketing authorisation ...

Significant advancements in lung cancer treatment were seen throughout 2024, from new drug approvals to promising clinical ...

CURE compiled the top stories in the lung cancer space, including treatment updates and the potential of cancer vaccines.

From tennis star Gabriela Dabrowski sharing details of her breast cancer journey to Greg Gumbel and Linda Lavin dying, here ...

By narrowing their research to overweight and obese individuals, Roswell Park researchers found that metformin might offer ...

Ian Smith is reflecting on 'good news' in his battle against terminal lung cancer.The Neighbours legend, who announced his ...

Results from a study called Mariposa found a regimen of Rybrevant and Lazcluze helped patients with a common form of advanced ...

The risk for lung cancer is especially high among those with rheumatoid arthritis who also have interstitial lung disease.